Seroatlas · Human Serome Atlas

CEP170P1

Cep170-like protein

Also known as: C170L_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: Q96L14
Gene: CEP170P1
Canonical length: 293 aa

OverviewNCBI Gene

No narrative summary is available for CEP170P1 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

293 residues, UniProt reviewed canonical sequence.

>Q96L14|CEP170P1
     1  MPTSSSFKHR IKEQEDYIRD WTAHREEIAR ISQDLALIAR EINDVAGEID SVTSSGTAPS
    61  TTLVDRVFDE SLNFQKIPPL VHSKTPEGNN GRSGDPRPQA AEPPDHLTIT RRRTWSRDEV
   121  MGDNLLLSSV FQFSKKIRQS IDKTAGKIRI LFKDKDRNWD DIESKLRAES EVPIVKTSSM
   181  EISSILQELK RVEKQLQAIN AMIDPDGTLE ALNNMGFPSA MLPSPPKQKS SPVNNHHSPG
   241  QTPTLGQPEA RALHPAAVSA AAEFENAESE ADFSIHFNRV NPDGEEEDVT VHK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CEP170P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Unknown
Secreted: No
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.58

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

identical protein binding

Protein domainsUniProt · Pfam · InterPro

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CEP170P1 as an antibody target. Whether an autoantibody or antibody against CEP170P1 could matter depends on whether native CEP170P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CEP170P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CEP170P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...